KR101109415B1 - A feed additives for prophylaxis and treatment of viral disease including newcastle disease and a feed composion - Google Patents
A feed additives for prophylaxis and treatment of viral disease including newcastle disease and a feed composion Download PDFInfo
- Publication number
- KR101109415B1 KR101109415B1 KR1020110036528A KR20110036528A KR101109415B1 KR 101109415 B1 KR101109415 B1 KR 101109415B1 KR 1020110036528 A KR1020110036528 A KR 1020110036528A KR 20110036528 A KR20110036528 A KR 20110036528A KR 101109415 B1 KR101109415 B1 KR 101109415B1
- Authority
- KR
- South Korea
- Prior art keywords
- poultry
- weight
- feed
- newcastle disease
- water
- Prior art date
Links
- 239000003674 animal food additive Substances 0.000 title claims abstract description 39
- 208000010359 Newcastle Disease Diseases 0.000 title claims description 27
- 201000010099 disease Diseases 0.000 title description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 16
- 230000003612 virological effect Effects 0.000 title description 11
- 238000011282 treatment Methods 0.000 title description 10
- 238000011321 prophylaxis Methods 0.000 title 1
- 244000144977 poultry Species 0.000 claims abstract description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 17
- 230000003253 viricidal effect Effects 0.000 claims abstract description 12
- 240000002234 Allium sativum Species 0.000 claims abstract description 11
- 244000144927 Aloe barbadensis Species 0.000 claims abstract description 10
- 235000002961 Aloe barbadensis Nutrition 0.000 claims abstract description 10
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 10
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 10
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 10
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 10
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 9
- 235000004611 garlic Nutrition 0.000 claims abstract description 9
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 8
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 7
- 241000711404 Avian avulavirus 1 Species 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 6
- 241000234282 Allium Species 0.000 claims abstract 4
- 230000008014 freezing Effects 0.000 claims abstract 2
- 238000007710 freezing Methods 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 12
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 12
- 241000700605 Viruses Species 0.000 claims description 12
- 229940010454 licorice Drugs 0.000 claims description 12
- 241000202807 Glycyrrhiza Species 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 9
- 238000010790 dilution Methods 0.000 claims description 6
- 239000012895 dilution Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 235000006533 astragalus Nutrition 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 244000068988 Glycine max Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 241001061264 Astragalus Species 0.000 claims description 3
- 210000004233 talus Anatomy 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims 2
- 235000020188 drinking water Nutrition 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 239000011812 mixed powder Substances 0.000 claims 2
- 241000269837 Artemisia dubia Species 0.000 claims 1
- 244000303040 Glycyrrhiza glabra Species 0.000 claims 1
- 244000046052 Phaseolus vulgaris Species 0.000 claims 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims 1
- 238000007865 diluting Methods 0.000 claims 1
- 241000411851 herbal medicine Species 0.000 claims 1
- 238000002156 mixing Methods 0.000 abstract description 9
- 239000004615 ingredient Substances 0.000 abstract description 8
- 244000046146 Pueraria lobata Species 0.000 abstract description 3
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 241000132011 Atractylodes lancea Species 0.000 abstract 1
- 240000003049 Canavalia gladiata Species 0.000 abstract 1
- 235000010518 Canavalia gladiata Nutrition 0.000 abstract 1
- 241000037831 Polygonatum sibiricum Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 238000007598 dipping method Methods 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 235000013594 poultry meat Nutrition 0.000 description 34
- 239000000523 sample Substances 0.000 description 10
- 235000013601 eggs Nutrition 0.000 description 9
- 239000012676 herbal extract Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000002131 composite material Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000341 volatile oil Substances 0.000 description 7
- 244000291564 Allium cepa Species 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 230000000069 prophylactic effect Effects 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 3
- 235000010081 allicin Nutrition 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000012470 diluted sample Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002434 immunopotentiative effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- -1 isovaleric acid ester Chemical class 0.000 description 3
- 125000004084 sesquiterpene group Chemical group 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- FCSSPCOFDUKHPV-UHFFFAOYSA-N 2-Propenyl propyl disulfide Chemical compound CCCSSCC=C FCSSPCOFDUKHPV-UHFFFAOYSA-N 0.000 description 2
- 241000045403 Astragalus propinquus Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 244000045232 Canavalia ensiformis Species 0.000 description 2
- 235000010520 Canavalia ensiformis Nutrition 0.000 description 2
- 108010062580 Concanavalin A Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 2
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- QSIXTSXIETZHGN-UHFFFAOYSA-N Uralene Chemical compound O1C2=CC=C(O)C(O)=C2C(=O)C(OC)=C1C1=CC(O)=C(O)C=C1CC=C(C)C QSIXTSXIETZHGN-UHFFFAOYSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UBAXRAHSPKWNCX-UHFFFAOYSA-N diallyl trisulfide Chemical compound C=CCSSSCC=C UBAXRAHSPKWNCX-UHFFFAOYSA-N 0.000 description 2
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N sinapic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- IUKHSWVQCORLGA-AYXADEGOSA-N (3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO IUKHSWVQCORLGA-AYXADEGOSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N 3‐isothujone Chemical compound CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- FQPGMQABJNQLLF-UHFFFAOYSA-N 4-aminooxy-2-azaniumylbutanoate Chemical compound NOCCC(N)C(O)=O FQPGMQABJNQLLF-UHFFFAOYSA-N 0.000 description 1
- DYARIVMCYYQNNQ-UHFFFAOYSA-N 7-hydroxy-2-(3-hydroxyphenyl)chromen-4-one Chemical compound OC1=CC=CC(C=2OC3=CC(O)=CC=C3C(=O)C=2)=C1 DYARIVMCYYQNNQ-UHFFFAOYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- 235000005255 Allium cepa Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 241000984235 Atractylodes koreana Species 0.000 description 1
- 241001519465 Avian metapneumovirus Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- UBJVUCKUDDKUJF-UHFFFAOYSA-N Diallyl sulfide Chemical compound C=CCSCC=C UBJVUCKUDDKUJF-UHFFFAOYSA-N 0.000 description 1
- YJHVMPKSUPGGPZ-UHFFFAOYSA-N Dihydro-beta-eudesmol Natural products C1CC(C(C)(C)O)CC2C(C)CCCC21C YJHVMPKSUPGGPZ-UHFFFAOYSA-N 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LLKXNMNOHBQSJW-UHFFFAOYSA-N Elemol Natural products CCC(=C)C1CC(C=CC1(C)C)C(C)(C)O LLKXNMNOHBQSJW-UHFFFAOYSA-N 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 241000711450 Infectious bronchitis virus Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930187719 Soyasaponin Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004712 air sac Anatomy 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- IPZIYGAXCZTOMH-UHFFFAOYSA-N alpha-eudesmol Natural products CC1=CCCC2CCC(CC12)C(C)(C)O IPZIYGAXCZTOMH-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- XFSVWZZZIUIYHP-UHFFFAOYSA-N beta-Eudesmol Natural products CC(C)(O)C1CCC2CCCC(=C)C2C1 XFSVWZZZIUIYHP-UHFFFAOYSA-N 0.000 description 1
- BOPIMTNSYWYZOC-VNHYZAJKSA-N beta-eudesmol Chemical compound C1CCC(=C)[C@@H]2C[C@H](C(C)(O)C)CC[C@]21C BOPIMTNSYWYZOC-VNHYZAJKSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- GFJIQNADMLPFOW-UHFFFAOYSA-N cis-Elemol Natural products CC(=C)C1CC(C(C)(C)O)CCC1(C)C=C GFJIQNADMLPFOW-UHFFFAOYSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- GFJIQNADMLPFOW-VNHYZAJKSA-N elemol Chemical compound CC(=C)[C@@H]1C[C@H](C(C)(C)O)CC[C@@]1(C)C=C GFJIQNADMLPFOW-VNHYZAJKSA-N 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 1
- WWULHQLTPGKDAM-UHFFFAOYSA-N gamma-eudesmol Natural products CC(C)C1CC(O)C2(C)CCCC(=C2C1)C WWULHQLTPGKDAM-UHFFFAOYSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 210000001821 langerhans cell Anatomy 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003129 oil well Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- PHZLMBHDXVLRIX-UHFFFAOYSA-M potassium lactate Chemical compound [K+].CC(O)C([O-])=O PHZLMBHDXVLRIX-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004202 respiratory function Effects 0.000 description 1
- 210000003660 reticulum Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- PCMORTLOPMLEFB-UHFFFAOYSA-N sinapinic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229930007110 thujone Natural products 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Fodder In General (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료 활성을 가지는 사료첨가제 및 사료조성물에 관한 것으로서, 구체적으로는 가금류에서 뉴캐슬병(Newcastle disease)을 예방하여 발병률을 감소시키거나 뉴캐슬병(Newcastle disease)의 치료에 유효한 사료첨가제에 관한 것이며, 또한, 상기 사료첨가제가 함유된 사료조성물에 관한 것이다.The present invention includes Newcastle disease of poultry The present invention relates to a feed additive and a feed composition having a prophylactic and therapeutic activity for viral diseases. Specifically, the present invention relates to a feed additive that is effective in preventing the occurrence of Newcastle disease in poultry and reducing the incidence or treating Newcastle disease. In addition, the present invention relates to a feed composition containing the feed additive.
조류를 포함하여 가금류의 뉴캐슬병(Newcastle disease)은 뉴캐슬 바이러스(paramyxovirdae paramyxovirus)에 의해 발생하는 것으로서, 뉴캐슬병(Newcastle disease)은 1926년 인도네시아 자바 및 잉글랜드의 뉴캐슬-어폰-타인(Newcastle-upon-Tyne) 지방의 조류에서 처음 발병한 것으로 알려져 있다.Newcastle disease in poultry, including birds, is caused by paramyxovirdae paramyxovirus, and Newcastle disease is caused by the Newcastle-upon-Tyne region of Java and England in 1926. It is known to be the first to occur in algae.
가금류의 뉴캐슬병(Newcastle disease)의 감염경로는 분비물, 대변, 호흡기 배설물 및 감염된 조류시체와의 직접적인 접촉 등 공기, 경구 등을 통하여 감염되며, 주요 증상으로는 기침, 호흡곤란, 식욕부진, 황백색 설사 후에 녹색 설사 등이 있고, 마비, 경련, 선회운동, 머리, 날개, 다리가 뒤틀림, 기낭 혼탁, 사낭?장?선위의 출혈반점이 나타난다.The infection path of poultry Newcastle disease is caused by air or oral, including secretions, feces, respiratory excretion, and direct contact with infected bird bodies.The main symptoms include cough, dyspnea, anorexia, and yellow-white diarrhea. Green diarrhea, paralysis, convulsions, turning movements, head, wings, leg twists, air bladder turbidity, bleeding spots in the sac and intestine.
가금류의 뉴캐슬병(Newcastle disease)은 일령에 관계없이 모든 일령에 발생하며, 전염성이 매우 높으며, 백신을 접종하지 않은 닭에 감염될 때는 100% 폐사율을 초래하는 가금류에 있어 무서운 제1종 법정 전염병으로서 매년 발생주의보를 발표하고 있으나, 발생이 계속 증가하고 있을 뿐 아니라 전국적으로 발생되는 추세에 있기 때문에 양계 농가에 큰 피해를 주고 있다.Newcastle disease in poultry occurs at any age, regardless of age, is a highly infectious, terrible first class infectious disease in poultry that causes 100% mortality when infected with unvaccinated chickens. Although an accrual announcement has been issued, the outbreak is not only on the rise, but is also occurring nationwide, causing serious damage to poultry farmers.
가금류의 뉴캐슬병(Newcastle disease)의 치료 및 예방과 관련된 선행기술로 예를 들면, 국내 공개특허공보 공개번호 10-2009-7012384호에 심황, 녹차, 생강, 고추냉이로부터 얻어지는 추출물을 이용하여 뉴캐슬병의 치료방법과 발병률 억제 방법을 개시하고 있으며, 국내 공개특허공보 공개번호 특2002-0041118호에는 세틸피리디늄 클로라이드를 함유하는 가금류의 뉴캐슬병의 치료 및 예방제제를 개시하고 있으나, 이들 선행기술은 질병의 예방 내지 치료제 그 자체로서 사료첨가물 및 사료조성물과는 직접적인 관련이 없으며 또 국내 등록특허공보 등록번호 10-0743861호에는 인플루엔자 A 바이러스, 뉴캐슬병 바이러스, 닭 전염성기관지염 바이러스, 조류 뉴모 바이러스 등의 바이러스로 인한 인간 질환의 치료 및 예방용 조성물을 개시하고 있으나 이는 인간의 질병에 대한 예방 및 치료제 관한 것이다.As a prior art related to the treatment and prevention of Newcastle disease of poultry, for example, Korean Patent Publication No. 10-2009-7012384, the treatment of Newcastle disease using extract obtained from turmeric, green tea, ginger, wasabi The present invention discloses a method and a method for suppressing incidence, and Korean Patent Laid-Open Publication No. 2002-0041118 discloses a treatment and prophylactic agent for Newcastle disease of poultry containing cetylpyridinium chloride. The therapeutic agent itself is not directly related to feed additives and feed compositions, and Korean Patent Publication No. 10-0743861 describes human diseases caused by viruses such as influenza A virus, Newcastle disease virus, chicken infectious bronchitis virus and avian pneumovirus. Therapeutic and prophylactic compositions are disclosed but these are human diseases. It relates to prevention and treatment.
본 발명은 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료활성을 가지는 사료첨가제의 제공 및 사료첨가제를 함유하는 사료조성물의 제공에 그 목적이 있으며, 보다 구체적으로는 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료 활성을 가지면서, 가금류의 면역을 증강하는데 효능이 우수하여, 가금류의 뉴캐슬병(Newcastle disease)을 효과적으로 예방 및 치료하는 사료첨가제의 제공에 목적이 있으며 또 이를 함유하는 사료조성물의 제공에 그 목적이 있는 것이다.The present invention includes Newcastle disease of poultry The purpose of the present invention is to provide a feed additive having a prophylactic and therapeutic activity for viral diseases and to provide a feed composition containing the feed additive, and more specifically, to include Newcastle disease of poultry. It has the purpose of providing a feed additive which effectively prevents and treats Newcastle disease of poultry, and has a high efficacy in enhancing the immunity of poultry while preventing and treating viral diseases. The purpose is to provide.
본 발명의 목적 달성을 위한 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료 활성을 갖는 사료첨가제의 조성성분으로는 감초(Glycyrrhiza uralensis, Licorice) 4 ~ 8중량%, 쑥(Folium Artemisiae Argyi) 4 ~ 8중량%, 마늘(Allium sativum L.) 5 ~ 9중량%, 양파(Allium cepa L.) 5 ~ 9중량%, 창출(Atractylodis Rhizoma) 7 ~ 10중량%, 갈근(Pueraria thunbergiana Benth) 7 ~ 10중량%, 황기(Astragalus membranaceus) 8 ~ 10중량%, 은행(ginkgo nut) 8 ~ 10중량%, 알로에 베라(aloe vera) 11 ~ 15중량% 및 작두콩(Canavalia ensiformis) 의 씨 11 ~ 15중량%로 이루어진다.Newcastle disease of poultry for achieving the object of the present invention Ingredients of feed additives with the prevention and treatment of viral diseases include licorice (Glycyrrhiza uralensis, Licorice) 4 to 8% by weight, mugwort (Folium Artemisiae Argyi) 4 to 8% by weight, garlic (Allium sativum L.) 5 ~ 9% by weight, onion (Allium cepa L.) 5-9%, Atractylodis Rhizoma 7-10%, Pueraria thunbergiana Benth 7-10%, Astragalus membranaceus 8-10% %, 8-10 wt% ginkgo nut, 11-15 wt% aloe vera, and 11-15 wt% seed of Canavalia ensiformis.
또한, 본 발명에 따른 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료 활성을 갖는 사료조성물은 상기 사료첨가제를 통상의 양계용 사료 100중량부에 대하여 0.1 내지 55 중량부로 배합하는 것으로 이루어진다.In addition, it includes Newcastle disease of poultry according to the present invention The feed composition having a prophylactic and therapeutic activity for viral diseases consists of blending the feed additive in an amount of 0.1 to 55 parts by weight based on 100 parts by weight of a conventional poultry feed.
상기 본 발명에 따른 사료첨가제의 성분으로 감초(Glycyrrhiza uralensis, Licorice)는 모든 약의 독성을 조화시켜서 약효가 잘 나타나게 하며 모든 혈맥의 소통을 잘 시키며 근육과 뼈를 튼튼히 하는 성분이며, 약리작용은 해독작용, 이뇨작용, 항염작용과 함께 소화성궤양을 억제한다. 감초의 근(根)과 근경(根莖)에는 트리테르펜(triterpene) 계(系) 사포닌(saponin), 글리시르히진(glycyrrhizin)이 함유되어 있으며, 글리시르히진산의 2-글루쿠론(glucuron)산 배당체가 감초의 감미성분이다. 이 배당체에는 혈액작용은 없으나 글리시르헤틴(glycyrrhetin)산은 혈액작용이 있으며, 글리시르헤틴(glycyrrhetin)산은 감초(根)의 가수분해 성분 중의 우랄렌 (uralen)산인 18α-글리시르헤틴산으로 함유되어 있다.Licorice (Glycyrrhiza uralensis, Licorice) as a component of the feed additive according to the present invention harmonizes the toxicity of all drugs to make the drug appear well and communicates well all blood vessels and strengthens muscles and bones, and the pharmacological action is detoxification. Inhibits peptic ulcer along with action, diuretic and anti-inflammatory effects. The roots and roots of licorice contain triterpene system saponin and glycyrrhizin, and 2-glucuron acid of glycyrrhizin acid. Glycosides are a sweet component of licorice. This glycoside has no blood action, but glycyrrhetin acid has blood action, and glycyrrhetin acid is contained as 18α-glycirrhetic acid, uralene acid in the hydrolysis component of licorice. have.
상기 쑥(Folium Artemisiae Argyi)은 오래전부터 강장보혈, 설사치료제로 쓰여 왔으며 애엽에는 0.02%의 정유(精油)가 함유되어 있으며, 주요 정유성분은 치네올(Cineol) 50%, 알칼로이드(alkaloids), 츄온(Thujone), 세스퀴터펜(Sesquiterpen), 세스퀴터펜 알코올(Sesquiterpen alcohol), 아데닌(Adenine) 0.02%, 콜린(Choline) 0.11%, 비타민 A, B, C, D 등을 함유하고 있다.The mugwort (Folium Artemisiae Argyi) has been used to treat tonic blood and diarrhea for a long time, and the leaflets contain 0.02% of essential oils, and the main essential oils are cineol 50%, alkaloids, and chuon (Thujone), Sesquiterpen, Sesquiterpen alcohol, Sesquiterpen alcohol, Adenine 0.02%, Choline 0.11%, Vitamin A, B, C, D and the like.
상기 마늘(Allium sativum L.)은 알리신, 유황화합물, 셀레늄, 비타민 B, C, E 등을 풍부하게 함유하고 있으며, 일반적으로 마늘에는 약 1%의 휘발성 정유가 함유되어 있으며, 그 중 60%는 디알릴 디설파이드이고 나머지는 알릴프로필 디설파이드, 디알릴 트리설파이드, 알리신 등으로 대부분이 황함유 화합물이다. 이 중 알리신은 비타민 B1과 결합하여 알리티아민이 되어 지속적으로 비타민 B1의 효과를 나타내며, 비타민 B2 및 비타민 C의 흡수를 도와준다. 또한, 항산화, 항균작용 및 항바이러스 효과에 탁월한 물질로서 각종 유해한 질병요인 세균들의 성장을 억제하여 유익한 세균총의 안정을 이끌어주어 질병에 대해 탁월한 항균, 항산화 효과를 지니고 있어 항생제 대체제로서 그 이용성이 탁월하며 세균 외에도 바이러스의 생육을 저지해 주는 효과를 지니고 있다.The garlic (Allium sativum L.) is rich in allicin, sulfur compounds, selenium, vitamins B, C, E, etc. In general, garlic contains about 1% of volatile essential oil, of which 60% Diallyl disulfide and the rest are allylpropyl disulfide, diallyl trisulfide, allicin and the like, mostly sulfur-containing compounds. Among them, allicin is combined with vitamin B1 to become an alliamine, which continuously shows the effects of vitamin B1 and helps absorption of vitamin B2 and vitamin C. In addition, it is an excellent anti-oxidant, antimicrobial and anti-viral effect, it inhibits the growth of various harmful disease factors bacteria, leads to the stability of beneficial bacteria total, and has excellent antimicrobial and anti-oxidant effects against diseases, and is excellent as an antibiotic replacement agent. In addition to bacteria has the effect of inhibiting the growth of viruses.
양파는 위 무력증, 장염에 효과가 있고, 살균작용을 보이며, 혈장콜레스테롤 상승을 억제하며, 피브린 용해활성을 하강시켜 동맥경화증에 사용되고 있다.Onion is effective in gastrointestinal discomfort and enteritis, has a bactericidal action, inhibits plasma cholesterol rise, and decreases fibrin lytic activity.
양파는 플라보이드류의 80% 이상이 퀘르세틴 디글리코시드(Quercetin diglycoside), 모노글리코시덴(Monoglycosiden), 퀘르세틴 아글리콘(Quercetin aglycone)으로 구성되어 있는 백합과(Liliaceae)에 속하며, 티올(thiol), 디메틸 디설피드, 디알릴-디설피드와 디알릴 티오에테르(thioether), 티오설핀 (thiosulfine)산 염과 같은 특수한 기미(氣味)를 가진 물질과 소량의 사과산염 등이 함유되어 있다. 뿌리, 구경(球莖), 잎에는 쿠마릭산(coumaric acid), 카페인산(caffeic acid), 페루린산(ferulic acid), 시나핀산(sinapic acid)이 함유되어 있다.Onions belong to the Liliaceae, which consists of more than 80% of the flavoids consisting of quercetin diglycoside, monoglycosiden and quercetin aglycone. It contains a small amount of special flavours such as dimethyl disulfide, diallyl-disulfide and diallyl thioether, thiosulfine acid salt and small amounts of malate. Roots, apertures, and leaves contain coumaric acid, caffeic acid, ferulic acid, and sinapic acid.
창출(Atractylodis Rhizoma)은 습열을 제거하고 위를 편하게 해주는 작용을 한다. 창출은 삽주의 다른 이름으로서 설사하는 것이 멎지 않는 것을 낫게 하며, 수종과 창만(脹滿)을 없앤다. 창출에는 약 1.5%의 정유와 카로틴, 이눌린, 고무질, 알카로이드 반응이 있고, 또한, 전초는 사포닌, 쿠마린 반응이 있다. 정유의 주성분은 세스키테르펜(Sesquiterpene)인 아트락틸론(C 15 H20 O, 녹는점 38℃, 약 20%)이며 이밖에 푸르푸랄, β-오이데스몰(β-Eudesmol), 히네솔, 아트락틸롤, 이소발레리안산에스테르, 아트락틸라트칼륨 등이 있다. 또한, 조선삽주(AtractylodesKoreana Kitam)의 뿌리(창출)의 정유 주성분은 아트락틸로딘이고, 아세틸아트락틸로디놀, 아트락틸로디놀, 엘레몰이 소량 들어 있다. 삽주의 정유 주성분인 아트락틸론은 매우 적거나 없다.Atractylodis Rhizoma works to remove moist heat and to make the stomach more comfortable. Creation is another name for the shovel that makes diarrhea better off inexhaustible, and eliminates species and spears. There are about 1.5% essential oils, carotene, inulin, gum and alkaloid reactions, and outposts have saponin and coumarin reactions. The main components of the essential oil are sesquiterpene, atlactilone (C 15 H20 O, melting point 38 ℃, about 20%), furfural, β-Eudesmol, henesol, art Lactylol, isovaleric acid ester, atactic lactate potassium and the like. In addition, the essential oil component of the root of the Atractylodes Koreana Kitam (creation) is atlactylodine, and contains a small amount of acetyl atlactylodinol, atlactylodinol, and elemol. There is very little or no atlactilone, the main component of the essential oil.
갈근(Pueraria thunbergiana Benth)은 칡뿌리의 껍질을 벗겨 잘게 썰어서 소금물 또는 백반수에 담갔다가 말린 것이며, 겉은 회백색의 섬유성이고 맛이 좀 쓰다. 골다공증을 예방하고 잠재적인 항바이러스성 효과를 나타내며, 체내에서 설사를 멎게 하는 작용을 하며, 면역저하증의 예방, 억제 및 치료에 우수한 면역증강 효능도 가지고 있다. 갈근의 성분은 푸에라린(puerarin), 다이드제인(daizein), 다이드진(daidzin) 등의 플라보노이드(flavonoid)계 화합물과 소야사포닌(soyasaponin) 등의 사포(saponin) 및 전분이 함유되어 있다.Brown root (Pueraria thunbergiana Benth) is peeled and finely chopped root roots, soaked in brine or white rice and dried. The outer part is grayish white fibrous and tastes bitter. It prevents osteoporosis, has potential antiviral effects, helps diarrhea in the body, and has an excellent immunopotentiating effect in the prevention, inhibition and treatment of immunosuppression. The root component contains flavonoid compounds such as puerarin, daizein and daidzin, and saponin and starch such as soyasaponin. .
황기(Astragalus membranaceus)는 면역증강 작용이 있어서 망상 내피 세포의 탐식 능력을 증강시키고, 만성기관지염, 기관지천식, 알레르기성 비염에 유효한 효과가 있으며, 백혈구감소증 등에도 효과가 있는 것으로 알려져 있다. 주요성분으로 플라보노이드(Flavonoid) 화합물인 7,3-디하이드록시-4-메톡시이소플라본(7,3-dihydroxy-4-methoxyisoflavone)을 함유하고 있으며 그 외, 포르모노네틴(Formononetin), 9-디메톡시프테로카르판(9-Dimethoxyptterocarpan) 등을 함유하고 있으며, 사포닌(Saponin) 성분으로 아스트라갈로사이드(Astragaloside), 당성분으로 D-글루코스(D-glucose), D-프룩토스(D-fructose), 수크로스(Sucrose) 등을 함유한다.Astragalus membranaceus has an immune enhancing effect to enhance the phagocytosis of reticulum endothelial cells, effective for chronic bronchitis, bronchial asthma, allergic rhinitis, leukopenia is known to be effective. Its main ingredient contains 7,3-dihydroxy-4-methoxyisoflavone, a flavonoid compound, and formononetin, 9- 9-Dimethoxyptterocarpan (9-Dimethoxyptterocarpan), etc., Saponin (Astragaloside) as a component, D-glucose (D-glucose), D-fructose (D- fructose), sucrose and the like.
은행(ginkgo nut)은 진해, 거담 등의 효능이 있는 것으로 알려져 있어, 해수, 천식, 유정, 소변의 백탁, 잦은 소변 등의 치료에 사용된다. 은행(배아)에 함유되어 있는 간놀, 펙틴, 히스티딘, 전분, 단백질, 지방, 당분 등은 폐결핵 천식, 기침, 가래에 효과적이며, 은행은 호흡기능의 염증을 소멸하며 결핵균의 발육을 억제하는 작용이 있다. 또한, 은행에는 신경쇠약, 전신피로 등의 뇌혈관을 개선해 주는 효능이 있다.Ginkgo nut is known to have effects such as cough and expectoration, and is used for the treatment of seawater, asthma, oil wells, whitening of urine and frequent urine. Ganol, pectin, histidine, starch, protein, fat, and sugar contained in ginkgo are effective for pulmonary tuberculosis asthma, cough and sputum. Ginkgo kills the inflammation of respiratory function and suppresses the development of Mycobacterium tuberculosis. have. In addition, the bank has the effect of improving the brain vessels, such as nervous breakdown, systemic fatigue.
알로에 베라(aloe vera)의 알로에 베라 겔은 분자량이 작은 면역조절제(G1C2F1)를 함유하고 있으며, 이것은 자외선으로 위축된 피부 랑거한스(Langerhans)세포의 기능을 회복시켜 주며, 상처치유, 항종양활성 그리고 대식세포를 활성화한다. 항바이러스, 항균, 근육이완작용(筋肉弛緩作用), 방사선방어, 항염, 면역증강 작용을 나타내며, 또한, 알로에 베라의 아세만난은 조류바이러스 질병의 백신 및 효과적인 항원 보강제로 사용되고 있으며, 닭의 마렉병과 뉴캐슬병 같은 바이러스질병 백신의 강한 보좌제로서의 활성이 있다.The aloe vera gel of aloe vera contains a small molecular weight immunomodulator (G1C2F1), which restores the function of UV-stretched skin Langerhans cells, and heals wounds, antitumor activity and Activate macrophages. It has antiviral, antibacterial, muscle relaxation, radiation defense, anti-inflammatory and immunopotentiating effects. Also, acemanan of Aloe vera is used as a vaccine and effective antigen adjuvant for avian virus disease. There is activity as a strong backing agent for viral disease vaccines such as Newcastle disease.
작두콩(Canavalia ensiformis) 씨에는 우레아제, 혈구응집소, 글루코시다제 카날린, 나바린 등의 아미노산, 녹말, 단백질, 기름성분 그리고 비타민A, B1, B2, B3, C 등이 함유되어 있어 영양이 매우 풍부하다. 특히, 혈구응집소는 콘카나발린A 등 여러 가지의 글로블린으로 되어있거나, 콘카나바린A(concanavalin A) 성분은 만노스/구루코스에 결하는 렉틴으로 시험관에서 마우스 림프구의 용해를 억제하며, 대식세포를 활성화할 수 있고, 조직 내 캔디다 알비칸스(Candida albicans)의 제거를 촉진시킨다.Canavalia ensiformis seeds are rich in nutrition because they contain amino acids such as urease, hemagglutinin, glucosidase canalin, and navarin, starches, proteins, oils, and vitamins A, B1, B2, B3, and C. Do. In particular, hemagglutinin is composed of various globulins such as concanavalin A, or concanavalin A is a lectin that binds to mannose / gurucose, which inhibits mouse lymphocyte lysis in vitro and activates macrophages. And promotes the removal of Candida albicans in tissues.
상기한 본 발명에 따른 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료활성을 가지는 사료첨가제 각각의 성분들은 통상적으로 재배 또는 시판하는 생약재료로부터 얻을 수 있으며, 특별히 제한되지 않으며, 상기한 각 성분들의 자연 그대로의 재료를 건조 및 분말화하고 상기한 본 발명에 따른 배합비로 혼합하여 사료첨가제로 제조될 수 있다.Including the Newcastle disease of poultry according to the present invention (Newcastle) Each of the ingredients of the feed additive having the prevention and treatment of viral diseases can be obtained from conventional herbal materials, which are usually grown or marketed, and are not particularly limited, and drying and powdering the raw materials of each of the above components It can be prepared as a feed additive by mixing in a blending ratio according to the present invention.
또한, 본 발명에 따른 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료활성을 가지는 사료첨가제의 또 다른 제조방법은 상기 사료첨가제의 각 성분들을 개별적으로 추출한 추출물을 배합하여 제조할 수 있을 뿐 아니라 사료첨가제의 조성성분들의 혼합물로부터 추출한 복합 생약추출물로 하여 사료첨가제를 제조할 수 있으며, 아래에 복합 생약 추출물에 의한 본 발명의 사료첨가제의 제조방법을 설명한다.In addition, it includes Newcastle disease of poultry according to the present invention Another method for preparing a feed additive having a prophylactic and therapeutic activity for a viral disease can be prepared by combining extracts extracted from each component of the feed additive, as well as a complex herbal extract extracted from a mixture of the components of the feed additive. It can be prepared a feed additive, it will be described below a method for producing a feed additive of the present invention by a composite herbal extract.
먼저, 상기한 사료첨가제의 조성성분인 감초, 쑥, 마늘, 양파, 창출, 갈근, 황기, 은행, 알로에 베라 및 작두콩 씨의 건조 또는 동결상태의 재료를 각각 세절한 다음 상기한 본 발명에 따른 배합비로 혼합하거나, 혼합하여 물에 10시간 내지 50시간, 바람직하게는 20시간 내지 30시간 침지시킨 후, 정제수(물), 탄소수 1 내지 4의 저급 알코올 또는 정제수(물)와 탄소수 1 내지 4의 저급 알코올의 혼합용매로부터 선택되는 용매를 사용하여 추출한 다음, 이 추출액을 여과 및 원심분리하고, 농축 및 동결 건조시켜 복합 생약 추출물을 제조하고 이를 본 발명에 따른 사료 첨가제로 한다.First, the dried or frozen state of the licorice, mugwort, garlic, onion, creation, brown root, Astragalus, ginkgo, aloe vera, and soybean seed, which are the components of the feed additive, respectively, are finely sliced, and then the combination ratio according to the present invention. After mixing or immersing in water for 10 hours to 50 hours, preferably 20 hours to 30 hours, and then purified water (water), lower alcohol of 1 to 4 carbon atoms or purified water (water) and lower of 1 to 4 carbon atoms After extraction using a solvent selected from a mixed solvent of alcohol, the extract is filtered and centrifuged, concentrated and freeze-dried to produce a composite herbal extract, which is used as a feed additive according to the present invention.
상기한 추출방법은 열수추출, 냉침추출, 환류 냉각추출 또는 초음파 추출 등을 이용할 수 있으며, 상기 사료첨가제의 조성성분의 혼합물인 재료혼합물의 중량에 대하여 1 내지 20배, 바람직하게는 5 내지 10배의 정제수를 포함한 물을 용매로 하여 10℃ 내지 200℃ 온도에서 10분 내지 10시간 열수추출하는 것이 바람직하며, 50℃ 내지 150℃ 온도에서 1시간 내지 2시간 동안 열수추출하는 것이 보다 바람직하다.The extraction method may use hot water extraction, cold extraction, reflux cooling extraction or ultrasonic extraction, and 1 to 20 times, preferably 5 to 10 times the weight of the material mixture, which is a mixture of the components of the feed additive. It is preferable to extract hot water at 10 ° C. to 200 ° C. for 10 minutes to 10 hours using water containing purified water as a solvent, and more preferably to extract hot water for 1 hour to 2 hours at a temperature of 50 ° C. to 150 ° C.
또 상기 원심분리과정은 원심분리기를 이용하여 -10℃ 내지 10℃ 온도에서 1,000rpm 내지 4,500rpm으로 2회 원심분리하며, 4℃ 온도에서 2,000rpm 내지 4,000rpm으로 원심분리하는 것이 보다 바람직하다.In addition, the centrifugation process is centrifuged twice at 1,000 rpm to 4,500 rpm at a temperature of -10 ° C. to 10 ° C. using a centrifuge, and more preferably at 2,000 rpm to 4,000 rpm at 4 ° C.
상기 본 발명에 따른 사료첨가제는 통상의 양계용 배합사료에 배합되어 사료로서 투여될 수 있으며, 통상의 양계용 배합사료는 시중에서 제조 판매되고 있는 양계용 배합사료로서 조단백 16중량%. 조지방 3중량%. 조섬유 6.5중량% 이하 칼슘 3.25%중량 이상, 인 0.37중량% 이상의 성분을 갖는 배합사료가 적당하며 시판되는 통상의 양계용 사료이면 어느 것을 사용해도 무방하다.The feed additive according to the present invention can be administered as a feed compounded in a conventional poultry compounded feed, the conventional poultry compounded feed is 16% by weight of crude protein as a poultry compounded commercially manufactured and sold on the market. 3% by weight crude fat. A blended feed having a content of at least 6.5% by weight of crude fiber and at least 3.25% by weight of calcium and at least 0.37% by weight of phosphorus is suitable, and any commercially available poultry feed may be used.
상기 본 발명에 다른 사료첨가제의 배합비율은 통상의 양계용 사료 100중량부에 대하여 약 0.01 내지 55중량부, 바람직하기로는 약 0.1 내지 35중량부, 더욱 바람직하기로는 약 1 내지 약 25중량부로 배합된다.The blending ratio of the feed additive according to the present invention is about 0.01 to 55 parts by weight, preferably about 0.1 to 35 parts by weight, more preferably about 1 to about 25 parts by weight, based on 100 parts by weight of conventional poultry feed. do.
본 발명에 따른 사료첨가제 및 이를 함유한 사료조성물은 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료활성을 가지면서 동시에 가금류의 면역증강의 효과를 나타내므로 가금류 사육을 위한 안전하고 효과적인 사료첨가제 및 사료조성물로 유용하게 이용될 수 있다.The feed additive and the feed composition containing the same according to the present invention includes Newcastle disease of poultry In addition to the prevention and treatment of viral diseases and at the same time show the effect of boosting the poultry immunity can be usefully used as a safe and effective feed additive and feed composition for poultry rearing.
또한, 본 발명에 따른 사료첨가제 및 이를 함유한 사료조성물은 양계의 체중을 증가시켜, 양계의 생산성 내지 육성률은 높이고, 폐사율은 감소시키는 안전성이 높은 고품질의 양계용 사료로 제공될 수 있을 뿐 아니라 가금의 음료수로 제공될 경우에도 가금류의 뉴캐슬병(Newcastle disease)을 포함하는 바이러스성 질병의 예방 및 치료활성을 가지면서 동시에 가금류의 면역증강의 효과를 나타내는 장점이 있다.In addition, the feed additive and the feed composition containing the same according to the present invention increases the weight of the poultry, can be provided as a high-quality poultry feed for high safety to increase the productivity or growth rate of the poultry, reducing mortality as well as Poultry's Newcastle disease, even when served as a drink of poultry It has the advantages of preventing and treating viral diseases and at the same time exhibiting the effects of immunopotentiation of poultry.
도 1은 종란실험과정을 나타낸 사진Figure 1 is a photograph showing the process of experiment
이하에서는 실시예에 의하여 본 발명을 더욱 구체적으로 설명하기로 한다. 그러나 후술하는 실시예는 본 발명을 한정하는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to Examples. However, the examples described below do not limit the present invention.
<실시예 1>≪ Example 1 >
마쇄기로 분쇄한 감초 8g, 쑥 8g, 마늘 8g, 양파 8g, 창출 10g, 갈근 10g 황기 10g, 은행 10g, 알로에 베라 14g 및 작두콩 씨 14g을 혼합하고, 60중량%의 에탄올용액 1ℓ를 가한 다음, 실온에서 18시간 환류 추출하고 여과한 후, 4℃ 3,000rpm에서 30분간 원심분리하여 침전물을 제거하고 상층액을 분리하였다.8 g of licorice crushed with a crusher, 8 g of wormwood, 8 g of garlic, 8 g of onions, 10 g of fresh root, 10 g of rhubarb, 10 g of rhubarb, 10 g of ginkgo, 14 g of aloe vera and 14 g of soybean seed, add 1 liter of 60 wt% ethanol solution, The mixture was extracted under reflux for 18 hours, filtered, and centrifuged at 4 ° C. 3,000 rpm for 30 minutes to remove precipitates, and the supernatant was separated.
분리된 맑은 상층액을 감압 하에서 증발 건조시켜 에탄올 성분을 완전히 제거하고, 증류수 200㎖를 첨가한 후 동결건조기(EYELA FDU-1100)로 동결 건조하여 복합 생약추출물 분말을 수득하였다(시료로 하기 위하여 4℃로 냉장 보관함).The separated supernatant was evaporated to dryness under reduced pressure to completely remove the ethanol component, 200 ml of distilled water was added, and then freeze-dried with a freeze dryer (EYELA FDU-1100) to obtain a composite herbal extract powder (4 for sample). Refrigerated at ℃).
<실시예 2><Example 2>
상기 <실시예 1>에서 제조한 복합 생약추출물 1g에 시판하는 양계용 배합사료 99g을 균일하게 배합하여 양계용 사료 조성물을 제조하였다.
The feed composition for poultry was prepared by uniformly mixing 99g of commercial feed for poultry in 1 g of the composite herbal extract prepared in <Example 1>.
<시험예><Test Example>
시험관 내 살바이러스 효능을 알아보기 위해 뉴캐슬병 바이러스(Newcastle disease virus: NDV)는 2010년 5월 4일 가축병성감정실시기관으로 지정된 농업회사법인 (주)반석L.T.C에서 분리된 야외농장의 ND Virus를 사용하여 10일령 SPF 종란에서 실험하였다(도면 1 사진 참고).Newcastle disease virus (NDV) uses ND Virus from an outdoor farm isolated from Banseok LTC Co., Ltd. 10 days old SPF eggs were tested (see Figure 1 photo).
본 발명에 따른 사료첨가제에 대한 시험관 내 살바이러스 효능(Virucidal activity)을 시험하기 위하여 상기 <실시예 1>에서 수득한 복합 생약추출물을 시료로 하고, 상기 시료분말인 복합생약추출물 1g을 증류수 100㎖에 용해시켜 100배 희석시료로 하고, 100배 희석시료를 증류수로 각각 10배 및 20배 희석하여, 1,000배 희석시료와 2,000배 희석시료로 하고, 또 100배 희석시료를 증류수로 40배 희석하여 4,000배 희석시료로 하였다.In order to test the in vitro virucidal activity (Virucidal activity) for the feed additive according to the present invention, the composite herbal extract obtained in Example 1 was used as a sample. 1 g of the composite herbal extract, which is the sample powder, is dissolved in 100 ml of distilled water to make a 100-fold dilution sample, and the 100-fold dilution sample is diluted 10-fold and 20-fold with distilled water, respectively, to a 1,000-fold dilution sample and a 2,000-fold dilution sample. The 100-fold diluted sample was diluted 40-fold with distilled water to obtain a 4,000-fold diluted sample.
상기 시료 희석액 2.5㎖가 들어있는 시험관에 1분 간격으로 준비된 바이러스액 2.5㎖를 시험관에 넣고 혼합한 다음, 정확히 30분 동안 반응시켰으며 10분 간격으로 잘 흔들어주었다. 대조군은 증류수를 시료로 사용하였다.2.5 ml of the virus solution prepared at intervals of 1 minute in a test tube containing 2.5 ml of the sample dilution solution was mixed in a test tube, and reacted for exactly 30 minutes, and shaken well at 10 minute intervals. The control group used distilled water as a sample.
상기의 희석된 시료 및 대조군의 시료 25㎕씩을 종란에 각 시험군별로 50개씩 접종하였다. 접종 후 37℃의 부란기에서 3일 동안 배양하면서 접종 24시간, 48시간, 72시간 후 검란하여 각 시간단위별로 중지란 수 및 상태를 관찰하였으며, 그 결과를 이래 [표 1]에 나타내었다.25 μl of the diluted sample and the control sample were inoculated into 50 eggs for each test group. After inoculation, the cells were incubated for 3 days at 37 ° C. incubation period and examined at 24 hours, 48 hours, and 72 hours after the inoculation to observe the number and status of the stop eggs for each time unit. The results are shown in Table 1 below.
상기 [표 1]에 나타난 바와 같이, 대조군 즉, 뉴캐슬병 바이러스를 접종한 유정란에서는 중지란이 50개 중 16개로 68%의 생존율을 나타내고, 계태아의 발육 저하가 관찰되었으나, 1,000배, 2,000배, 4,000배 희석하여 ND바이러스와 1:1 비율로 30분 동안 반응시킨 후의 시료 즉, 상기 본 발명에 따른 시료를 접종한 유정란에서는 중지란이 감소하였고, 계태아에 발육도 정상적으로 관찰되었다.As shown in Table 1, the control group, ie, fertilized eggs inoculated with Newcastle disease virus, showed a survival rate of 68% with 16 out of 50 eggs, and decreased development of chicks, but 1,000-fold, 2,000-fold, In the fertilized eggs inoculated with 4,000-fold dilution with the ND virus at a 1: 1 ratio for 30 minutes, that is, inoculated with the sample according to the present invention, stop eggs were reduced, and embryonic development was normally observed.
특히, 1,000배 희석한 실험군은 1개의 중지란 발생으로 생존율 98%로 가장 좋은 결과를 얻을 수 있었으며, 2,000배, 4,000배는 각 생존율 86%, 76%로 상기시료가 적게 함유될수록 생존율이 낮아지는 것을 알 수 있었다.In particular, the experimental group diluted 1,000-fold was able to obtain the best results with a survival rate of 98% due to the occurrence of one stop egg, and 2,000-fold, 4,000-fold survived 86% and 76%, respectively, and the survival rate decreased as the sample contained less. I could see that.
상기 시험결과에 나타난 바와 같이, 본 발명에 따른 사료첨가제(복합생약추출물)가 유정란 내 살바이러스 효능이 있음을 확인할 수 있다.As shown in the test results, it can be confirmed that the feed additive (composite herbal extract) according to the present invention has virucidal efficacy in fertilized eggs.
Claims (9)
9. The Newcastle disease of poultry according to claim 8, wherein the dilution concentration of the feed additive to water is 0.01 to 99.99% by weight. Poultry drinking water with virucidal efficacy against the virus.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110036528A KR101109415B1 (en) | 2011-04-20 | 2011-04-20 | A feed additives for prophylaxis and treatment of viral disease including newcastle disease and a feed composion |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020110036528A KR101109415B1 (en) | 2011-04-20 | 2011-04-20 | A feed additives for prophylaxis and treatment of viral disease including newcastle disease and a feed composion |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101109415B1 true KR101109415B1 (en) | 2012-01-31 |
Family
ID=45614706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020110036528A KR101109415B1 (en) | 2011-04-20 | 2011-04-20 | A feed additives for prophylaxis and treatment of viral disease including newcastle disease and a feed composion |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101109415B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101888555B1 (en) * | 2014-09-26 | 2018-08-16 | 신대용 | Composition comprising dried mixture of red shale and herbal medicine for immune enhancement |
KR102239870B1 (en) * | 2020-06-11 | 2021-04-13 | 강동오 | Feed additive for layer chicken comprising onion by-product as effective component and uses thereof |
KR20210132882A (en) * | 2020-04-28 | 2021-11-05 | 김창섭 | Method of manufacturing chicken feed using allium tuberosum |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2813471B2 (en) | 1994-06-16 | 1998-10-22 | 山之内製薬株式会社 | Crude drug-containing feed |
KR100725926B1 (en) | 2005-09-15 | 2007-06-11 | 충북바이오축산 영농조합법인 | Feed containing garlic for chicken |
KR100923771B1 (en) | 2007-10-11 | 2009-10-27 | 충북바이오축산 영농조합법인 | Method for raising poultry using non-antibiotics feed |
KR20100085763A (en) * | 2009-01-21 | 2010-07-29 | 전북대학교산학협력단 | A bacterium salmonella expressing chicken interferon alpha protein and composition thereof |
-
2011
- 2011-04-20 KR KR1020110036528A patent/KR101109415B1/en not_active IP Right Cessation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2813471B2 (en) | 1994-06-16 | 1998-10-22 | 山之内製薬株式会社 | Crude drug-containing feed |
KR100725926B1 (en) | 2005-09-15 | 2007-06-11 | 충북바이오축산 영농조합법인 | Feed containing garlic for chicken |
KR100923771B1 (en) | 2007-10-11 | 2009-10-27 | 충북바이오축산 영농조합법인 | Method for raising poultry using non-antibiotics feed |
KR20100085763A (en) * | 2009-01-21 | 2010-07-29 | 전북대학교산학협력단 | A bacterium salmonella expressing chicken interferon alpha protein and composition thereof |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101888555B1 (en) * | 2014-09-26 | 2018-08-16 | 신대용 | Composition comprising dried mixture of red shale and herbal medicine for immune enhancement |
KR20210132882A (en) * | 2020-04-28 | 2021-11-05 | 김창섭 | Method of manufacturing chicken feed using allium tuberosum |
KR102388613B1 (en) | 2020-04-28 | 2022-04-20 | 김창섭 | Method of manufacturing chicken feed using allium tuberosum |
KR102239870B1 (en) * | 2020-06-11 | 2021-04-13 | 강동오 | Feed additive for layer chicken comprising onion by-product as effective component and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alagawany et al. | Use of liquorice (Glycyrrhiza glabra) in poultry nutrition: Global impacts on performance, carcass and meat quality | |
Jimoh et al. | Comparison of the nutritive value, antioxidant and antibacterial activities of Sonchus asper and Sonchus oleraceus | |
Stintzing et al. | Cactus stems (Opuntia spp.): A review on their chemistry, technology, and uses | |
Jimoh et al. | Polyphenolic and biological activities of leaves extracts of Argemone subfusiformis (Papaveraceae) and Urtica urens (Urticaceae) | |
Franz et al. | Study on the assessment of plants/herbs, plant/herb extracts and their naturally or synthetically produced components as ‘additives’ for use in animal production | |
JP7471393B2 (en) | Tea composition having preventive or ameliorative effects on respiratory diseases and pharmaceutical composition containing the same | |
KR20130039495A (en) | Composition comprising herbal extracts for inhibiting growth of newcastle disease virus or avian influenza virus | |
Chollom et al. | Phytochemical analysis and antiviral potential of aqueous leaf extract of Psidium guajava against newcastle disease virus in ovo | |
Middleditch | Kuwaiti Plants: Distribution, Traditional Medicine, Pytochemistry, Pharmacology and Economic Value | |
Khursheed et al. | Phytochemical and pharmacological investigations on Adhatoda zeylanica (medic.): A review | |
KR100755983B1 (en) | Composition for stimulating hair growth and preventing depilation containing bamboo extract | |
CN106389788B (en) | It is a kind of for enhancing the drug extract, preparation and preparation method of immunologic function of livestock and birds and anti-virus ability | |
KR101109415B1 (en) | A feed additives for prophylaxis and treatment of viral disease including newcastle disease and a feed composion | |
Sim et al. | Preliminary investigation on the chemical composition of local medicinal herbs (Curcuma longa L., Persicaria odorata L. and Eleutherine palmifolia L.) as potential layer feed additives for the production of healthy eggs | |
KR102564887B1 (en) | Composition for preventing or improving respiratory disease | |
Moorthy et al. | Hemidesmus indicus (L.) R. BR.: an overview | |
Ramgopal et al. | Evaluation of antilipidemic and anti-obesity efficacy of Bauhinia purpurea bark extract on rats fed with high fat diet | |
Ezejindu et al. | Hepatoprotective Effects of Moringa Oleifera Leaf Extract On The Kidneys of Adult Wistar Rats | |
Soni et al. | Traditional uses, phytochemistry and pharmacological profile of Bambusa arudinacea Retz | |
US7399491B2 (en) | Health promoting functional foods fortified with herbs | |
Mgbojikwe et al. | The evaluation of the anticoccidial properties of aqueous leaf extract of Moringa oleifera | |
KR102459907B1 (en) | Health supplement food composition for improving respiratory diseases and health supplement food using the same | |
KR101028073B1 (en) | Natural herb medicine composition improving blood circulation and immune activity of human body and its process of production | |
Bharadwaj et al. | Scope of utilization of tannin & saponin to improve animal performance | |
Munglue et al. | Effects of Bauhinia strychnifolia Craib leaf extract on growth parameters and intestinal morphology of catfish (Clarias gariepinus) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |